Sinclair Pharma is a United Kingdom-based company founded in 1971 that operates within the manufacturing sector, specifically in pharmaceuticals and medical devices. With an employee size ranging from 501 to 1,000, the company reported revenue of approximately $288.6 million. Sinclair Pharma specializes in the development and distribution of medical devices aimed at aesthetic and therapeutic applications. One of its key products, the Reaction device, is indicated for temporary reduction of cellulite and body contouring, as well as relief from minor muscle aches and improvement of local blood circulation. The company provides detailed safety and performance information for its products, including contraindications for use, which encompass a range of medical conditions and prior treatments that may affect patient eligibility. The technical report published in January 2025 outlines these considerations, emphasizing the importance of qualified practitioners in assessing patient suitability and ensuring comprehensive pre- and post-treatment care.